U.S. Markets close in 29 mins
  • S&P 500

    3,397.71
    -3.26 (-0.10%)
     
  • Dow 30

    27,537.82
    -147.56 (-0.53%)
     
  • Nasdaq

    11,437.71
    +78.77 (+0.69%)
     
  • Russell 2000

    1,592.01
    -13.20 (-0.82%)
     
  • Crude Oil

    39.51
    +0.95 (+2.46%)
     
  • Gold

    1,909.00
    +3.30 (+0.17%)
     
  • Silver

    24.49
    +0.07 (+0.29%)
     
  • EUR/USD

    1.1818
    +0.0004 (+0.0355%)
     
  • 10-Yr Bond

    0.7780
    -0.0230 (-2.87%)
     
  • Vix

    33.12
    +0.66 (+2.03%)
     
  • GBP/USD

    1.3056
    +0.0036 (+0.2729%)
     
  • USD/JPY

    104.4820
    -0.3530 (-0.3367%)
     
  • BTC-USD

    13,644.09
    +536.86 (+4.10%)
     
  • CMC Crypto 200

    270.56
    +9.27 (+3.55%)
     
  • FTSE 100

    5,728.99
    -63.02 (-1.09%)
     
  • Nikkei 225

    23,485.80
    -8.54 (-0.04%)
     

Rite Aid: Q4 Earnings Insights

Benzinga Insights
·1 min read

Shares of Rite Aid (NYSE:RAD) fell 3% in pre-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share decreased 3600.00% over the past year to ($0.37), which missed the estimate of ($0.15).

Revenue of $5,727,000,000 rose by 6.45% year over year, which beat the estimate of $5,590,000,000.

Guidance Rite Aid said it expects FY21 sales of $22.5 billion to $22.9 billion, versus analysts' estimates of $22.3 billion. Details Of The Call

Date: Apr 16, 2020

Time: 10:01 AM ET

View more earnings on RAD

Webcast URL: https://www.riteaid.com/corporate/investor-relations/presentations

Technicals

52-week high: $23.88

Company's 52-week low was at $0.43

Price action over last quarter: Up 7.70%

Company Description

Rite Aid is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal-care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.